© 2021 MJH Life Sciences and Cancer Network. All rights reserved.
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
Univerzitetni kliniÄ?ni center Ljubljana
Å lajmerjeva 3
June 12, 2019
Cancer Network spoke with Ryan J. Sullivan, MD, of Massachusetts General Hospital, about the debate between immunotherapy sequencing vs targeted therapy for melanoma.
April 15, 2019
This review summarizes the current available treatment strategies for patients with advanced melanoma when PD-1–directed therapy is not enough.
April 04, 2019
Cancer Network spoke with Ryan J. Sullivan, MD, about the efficacy and safety of entinostat plus pembrolizumab in patients previously treated with immunotherapy.
January 04, 2019
Cancer Network speaks with Dr. Ryan J. Sullivan about adjuvant therapies in development for melanoma patients.
May 30, 2018
Medical oncologist Ryan J. Sullivan shared some interesting melanoma-related presentations from the 2018 ASCO Annual Meeting.
February 15, 2015
In early 2015, determining the optimal treatment regimen for a patient with metastatic melanoma remains challenging.